Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Oesophageal doppler monitoring company Deltex Medical reported a fall in revenue owing to the impact of COVID-19 and the associated significant reduction in elective surgical procedures worldwide.
For the year ended 31 December, revenue dropped to £2.4 million from £4.3 million year-on-year.
Cash as at 31 December 2020, stood at £0.9 million, unchanged from last year.
At 9:09am: (LON:DEMG) Deltex Medical Group PLC share price was 0p at 1.3p